
Objection to the Draft Commission Implementing Regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor (D067115-02)
Adopted
Reference: B9-0203/2020
Date: 09.07.2020
PfEIdentity and Democracy (ID)
23 Members
Group Voting Result
- 15For
- 2Against
- 6Abstention
- 0Did not vote
Majority of the group: For · 8 deviate
Majority = position with the most votes in the group; "Did not vote" does not count. In case of a tie there is no majority and no deviators.
Group Members


Nicolas Bay

Mathilde Androuët

André Rougé

Georg Mayer

Markus Buchheit

Virginie Joron

Jordan Bardella

Thierry Mariani

Roman Haider

Christine Anderson

Catherine Griset

France Jamet

Philippe Olivier

Harald Vilimsky

Jaak Madison

Ivan David

Isabella Tovaglieri

Gerolf Annemans

Paolo Borchia

Susanna Ceccardi

Tom Vandendriessche
